Wed Dec 14, 2022 12:00 AM Last update on: Wed Dec 14, 2022 06:19 AM
AFP, Zurich
Wed Dec 14, 2022 12:00 AM Last update on: Wed Dec 14, 2022 06:19 AM
The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said yesterday.
Comments